CA Stock MarketDetailed Quotes

Big Pharma Split Corp (PRM)

Watchlist
  • 14.150
  • -0.040-0.28%
15min DelayMarket Closed Apr 16 16:00 ET
17.21MMarket Cap-7.26P/E (TTM)

Big Pharma Split Corp (PRM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
Operating cash flow (Indirect Method)
Cash flow from continuing operating activities
1.27M
Net income from continuing operations
16.54%-538.62K
-127.01%-645.35K
-43.24%2.39M
2,036.51%4.21M
-108.43%-217.39K
22.57%2.58M
761.50%2.1M
---318.2K
Operating gains losses
----
----
----
----
----
----
--931.04K
----
Unrealized gains and losses of investment securities
----
----
----
----
----
----
---4.09M
----
Other non cashItems
-274.76%-7.95K
48.98%-2.12K
98.21%-4.16K
---231.53K
----
----
--2.38M
----
Change in working capital
-229.19%-12.48K
-94.49%9.66K
213.67%175.39K
-386.97%-154.29K
-951.93%-31.68K
94.42%-3.01K
-199.72%-53.96K
--54.11K
-Change in other current liabilities
-229.19%-12.48K
-94.49%9.66K
213.67%175.39K
-386.97%-154.29K
-951.93%-31.68K
---3.01K
----
--54.11K
Cash from discontinued operating activities
Operating cash flow
-85.57%1.71M
950.88%11.86M
112.54%1.13M
-306.98%-9M
-49.90%4.35M
583.04%8.68M
104.11%1.27M
---30.95M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-2.71M
Net commonstock issuance
97.79%-117.79K
-1,431.26%-5.32M
-94.72%399.78K
549.06%7.57M
53.89%-1.69M
-1,280.08%-3.66M
-101.30%-265.09K
--20.4M
Net preferred stock issuance
125.47%1.28M
-1,147.51%-5.04M
-91.63%481.16K
565.60%5.75M
56.34%-1.23M
-1,380.17%-2.83M
-101.40%-191K
--13.6M
Cash dividends paid
3.26%-2.04M
19.39%-2.11M
7.76%-2.62M
-63.83%-2.84M
16.93%-1.73M
7.53%-2.08M
---2.25M
--0
Net other financing activities
--0
--0
--0
--0
--0
--0
----
--0
Cash from discontinued financing activities
Financing cash flow
92.92%-882.46K
-617.83%-12.47M
-117.04%-1.74M
319.13%10.19M
45.71%-4.65M
-216.27%-8.57M
-108.28%-2.71M
--32.74M
Net cash flow
Beginning cash position
-75.07%204.19K
-42.71%819.21K
518.99%1.43M
-56.91%230.99K
28.53%536.06K
-77.40%417.07K
--1.85M
--0
Current changes in cash
235.26%828.33K
-0.58%-612.38K
-151.02%-608.87K
493.10%1.19M
-376.37%-303.61K
107.64%109.86K
-180.79%-1.44M
--1.78M
Effect of exchange rate changes
28.77%-1.88K
-51.61%-2.64K
-132.49%-1.74K
467.60%5.36K
-115.96%-1.46K
-12.12%9.13K
-83.89%10.39K
--64.48K
End cash position
404.75%1.03M
-75.07%204.19K
-42.71%819.21K
518.99%1.43M
-56.91%230.99K
28.53%536.06K
-77.40%417.07K
--1.85M
Free cash from
-85.57%1.71M
950.88%11.86M
112.54%1.13M
-306.98%-9M
-49.90%4.35M
583.04%8.68M
104.11%1.27M
---30.95M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
(FY)Dec 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017
Operating cash flow (Indirect Method)
Cash flow from continuing operating activities 1.27M
Net income from continuing operations 16.54%-538.62K-127.01%-645.35K-43.24%2.39M2,036.51%4.21M-108.43%-217.39K22.57%2.58M761.50%2.1M---318.2K
Operating gains losses --------------------------931.04K----
Unrealized gains and losses of investment securities ---------------------------4.09M----
Other non cashItems -274.76%-7.95K48.98%-2.12K98.21%-4.16K---231.53K----------2.38M----
Change in working capital -229.19%-12.48K-94.49%9.66K213.67%175.39K-386.97%-154.29K-951.93%-31.68K94.42%-3.01K-199.72%-53.96K--54.11K
-Change in other current liabilities -229.19%-12.48K-94.49%9.66K213.67%175.39K-386.97%-154.29K-951.93%-31.68K---3.01K------54.11K
Cash from discontinued operating activities
Operating cash flow -85.57%1.71M950.88%11.86M112.54%1.13M-306.98%-9M-49.90%4.35M583.04%8.68M104.11%1.27M---30.95M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -2.71M
Net commonstock issuance 97.79%-117.79K-1,431.26%-5.32M-94.72%399.78K549.06%7.57M53.89%-1.69M-1,280.08%-3.66M-101.30%-265.09K--20.4M
Net preferred stock issuance 125.47%1.28M-1,147.51%-5.04M-91.63%481.16K565.60%5.75M56.34%-1.23M-1,380.17%-2.83M-101.40%-191K--13.6M
Cash dividends paid 3.26%-2.04M19.39%-2.11M7.76%-2.62M-63.83%-2.84M16.93%-1.73M7.53%-2.08M---2.25M--0
Net other financing activities --0--0--0--0--0--0------0
Cash from discontinued financing activities
Financing cash flow 92.92%-882.46K-617.83%-12.47M-117.04%-1.74M319.13%10.19M45.71%-4.65M-216.27%-8.57M-108.28%-2.71M--32.74M
Net cash flow
Beginning cash position -75.07%204.19K-42.71%819.21K518.99%1.43M-56.91%230.99K28.53%536.06K-77.40%417.07K--1.85M--0
Current changes in cash 235.26%828.33K-0.58%-612.38K-151.02%-608.87K493.10%1.19M-376.37%-303.61K107.64%109.86K-180.79%-1.44M--1.78M
Effect of exchange rate changes 28.77%-1.88K-51.61%-2.64K-132.49%-1.74K467.60%5.36K-115.96%-1.46K-12.12%9.13K-83.89%10.39K--64.48K
End cash position 404.75%1.03M-75.07%204.19K-42.71%819.21K518.99%1.43M-56.91%230.99K28.53%536.06K-77.40%417.07K--1.85M
Free cash from -85.57%1.71M950.88%11.86M112.54%1.13M-306.98%-9M-49.90%4.35M583.04%8.68M104.11%1.27M---30.95M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More